The Cell-NCI Symposium: Beyond Cancer Genomics Toward Precision Oncology is taking place virtually from October 4-6, 2021 and will showcase multi-omics approaches to functional characterization of candidate cancer drug targets. Register before October 2.
CTD²: Cancer Target Discovery and Development
The Cancer Target Discovery and Development (CTD2) Network, a functional genomics initiative, bridges the gap between cancer genomics and biology. The Network aims to understand how tumor heterogeneity leads to drug resistance in order to develop optimal combinations of chemotherapy or small molecules in combination with immunotherapy.